Skip to content

Clinical trials

Phase 1 Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: Canada Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20066
20079
200810
20095
20104
20117
20128
20135
20149
20157
201610
20179
20189
20198
202011
20218
20227
20236
20247
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Terminated27
Recruiting16
Active, not recruiting14
Unknown status4
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline18
Novartis Pharmaceuticals9
Bristol-Myers Squibb8
Hoffmann-La Roche8
Merck Sharp & Dohme LLC8
AbbVie7
Janssen Research & Development, LLC6
Pfizer6
Amgen5
Boehringer Ingelheim5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms158
Carcinoma, Non-Small-Cell Lung28
Colorectal Neoplasms16
Breast Neoplasms14
Neoplasm Metastasis12
Ovarian Neoplasms12
Melanoma11
Squamous Cell Carcinoma of Head and Neck11
Prostatic Neoplasms8
Triple Negative Breast Neoplasms8

Trials

Showing 1 to 25 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.